Business / Finance

RSS

Fast and focused sequencing from single genes to entire exomes

Integrated DNA Technologies (IDT) will host a talk on maximizing efficiency of NGS enrichment panels at the qPCR & NGS 2015 Advanced Molecular Diagnostics for Biomarker Discovery Symposium on Monday March 23rd at 3PM. The talk will detail current technical issues faced by researchers when using hybridization enrichment panels and provide practical advice on how to increase successes while reducing time and costs in targeted sequencing.

From Integrated DNA Technologies 16 Mar 2015

Preventing falls in care homes: an interview with Professor Pip Logan

Older people living in care homes fall three times more frequently than individuals who still live in their own homes. There is often debate over the idea of people going into care homes as a solution to the fact they are falling at home but they can still fall in the care home.

16 Mar 2015

Egalet announces net revenues of $1.9 million for 2014

Egalet Corporation today reported financial results for the year ended December 31, 2014.

16 Mar 2015

Ruthigen, Pulmatrix sign definitive merger agreement

Ruthigen, Inc., a biopharmaceutical company, and Pulmatrix, Inc., a Lexington, Massachusetts based clinical stage biotechnology company, announced today that on March 13, 2015, they have entered into a definitive merger agreement.

16 Mar 2015

Experts call for a tobacco-free world by 2040

Leading public health researchers have called for the sale of tobacco to be phased out by 2040, showing that with sufficient political support and stronger evidence-based action against the tobacco industry, a tobacco-free world – where less than 5% of adults use tobacco – could be possible in less than three decades.

16 Mar 2015

Boris backs Bump Mark with £20,000 prize

Brunel graduate Solveiga Pakstaite has added the Mayor of London’s Low Carbon Entrepreneur prize to the Dyson Award she won for her innovative final-year food label project – the Bump Mark.

16 Mar 2015

BioSpecifics Technologies provides corporate update, reports Q4 and FY 2014 financial results

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced its financial results for the fourth quarter and full year ended December 31, 2014 and provided a corporate update.

13 Mar 2015

Par Pharmaceutical files registration statement with SEC for initial public offering of common stock

Par Pharmaceutical Holdings, Inc. today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock.

13 Mar 2015

Corizon Health partners with MBI to provide health services to the District of Columbia's DOC

Corizon Health, the nation's leader in correctional healthcare solutions, announced today it has partnered with D.C.-based MBI Health Services, LLC to provide health services to the District of Columbia's Department of Corrections.

12 Mar 2015

CannTrust, Canabo to partner on medical marijuana research project

CannTrust, Canada's only pharmacist-controlled licensed producer and distributor of medical cannabis today announced a collaboration with Canabo Medical Corporation to partner on a research project on marijuana for medical purposes.

12 Mar 2015

Cardiome Pharma records net loss of $18.2 million for 2014

Cardiome Pharma Corp. today reported financial results for its fourth quarter and year ended December 31, 2014. Amounts, unless specified otherwise, are expressed in U.S. dollars and in accordance with generally accepted accounting principles used in the United States of America (U.S. GAAP).

12 Mar 2015

Ember Therapeutics, Mariel Therapeutics sign definitive merger agreement

Ember Therapeutics, Inc., a Boston-based biotechnology company dedicated to the discovery and development of novel obesity and diabetic related therapies, and Mariel Therapeutics, a privately held, New York-based biotechnology company developing targeted therapies for osteoarthritis and kidney fibrosis using Bone Morphogenetic Protein (BMP)-7, jointly announce today that they have entered into a definitive agreement to merge the two companies.

12 Mar 2015

Oxis Biotech executes licensing agreement with MCIT for development of antibody-drug conjugates

Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of a definitive licensing and development agreement with MultiCell Immunotherapeutics, Inc. concerning the development of certain antibody-drug conjugates (ADCs).

12 Mar 2015

Norgine partners with Arc Medical to commercialize and distribute ENDOCUFF VISION

Norgine and Arc Medical Design Ltd. today announced a partnership that will see Norgine commercialising and distributing ENDOCUFF VISION, a Class 1 sterile medical device used in colonoscopy, across a number of major European markets, Australia and New Zealand. Norgine's first launch of ENDOCUFF VISION will take place in the UK Q2 2015.

12 Mar 2015

BeiGene chooses SAFC's CHOZN Platform to support oncology drug development

Sigma-Aldrich Corporation today announced that SAFC Commercial, its custom manufacturing services business unit, has entered a commercial sales and service contract with leading biopharmaceutical company, BeiGene.

11 Mar 2015

Green Cross makes investment in cell therapy sector in China

Green Cross, a South Korean biopharmaceutical company, today announced that it had signed MOU on the 6th of March with the Guizhou provincial government of China for the investment in the cell therapy sector in China.

11 Mar 2015

Chromogenex US, LiLa sign distribution agreement for i-lipo and i-lipo Ultra body sculpting systems

Chromogenex US, Inc., of Howell, Michigan, the sister company of Chromogenex Technologies, Ltd., and LiLa Enterprise, LLC of Suwanee, Georgia, announced today a strategic alliance wherein Chromogenex US appoints LiLa the exclusive distributor for the i- lipo and i-lipo Ultra body sculpting systems that employ low level laser technology for smoothing cellulite, fat reduction and body shaping treatments.

11 Mar 2015

USAP, Pinnacle announce new partnership with Excel Anesthesia

U.S. Anesthesia Partners, the nation's largest anesthesia-focused, single-specialty physician services organization, and Pinnacle Anesthesia Consultants of Dallas, Texas today announced their partnership with Excel Anesthesia, P.A.

11 Mar 2015

One World Cannabis, Sheba Academic Medical Center ink collaboration agreement

OWC Pharmaceutical Research Corp.'s wholly owned subsidiary One World Cannabis Ltd. signed a collaboration agreement with Sheba Academic Medical Center, the largest hospital in Israel and in the Middle East.

11 Mar 2015

MDC scientists identify new molecular signaling pathway that regulates placental development

During pregnancy, the mother supplies the fetus with nutrients and oxygen via the placenta. If placental development is impaired, this may lead to growth disorders of the embryo or to life-threatening diseases of the mother such as preeclampsia, a serious condition involving high blood pressure and increased urinary protein excretion.

11 Mar 2015